George Nahass, MD
Dermatopathology · Glen Carbon, ILNPI 1215902986
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 304 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations.
Across 304 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$786
- Lilly USA, LLC$597
- Novartis$467
- UCB, Inc.$338
- Johnson & Johnson$334
- Regeneron Healthcare Solutions, Inc.$306
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,80698%
- Education$772%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 48 | $786 |
| Lilly USA, LLC | 41 | $597 |
| Novartis | 22 | $467 |
| UCB, Inc. | 21 | $338 |
| Johnson & Johnson | 20 | $334 |
| Regeneron Healthcare Solutions, Inc. | 18 | $306 |
| Amgen | 12 | $239 |
| Sanofi | 9 | $185 |
| LEO Pharma Inc. | 10 | $176 |
| Pfizer | 11 | $175 |
| Incyte Corporation | 8 | $172 |
| Sun Pharmaceutical Industries Inc. | 10 | $170 |
| Bristol Myers Squibb | 23 | $132 |
| Galderma Laboratories, L.p. | 8 | $124 |
| E.r. Squibb & Sons, L.L.C. | 7 | $106 |
| Almirall LLC | 6 | $100 |
| Genentech USA, Inc. | 6 | $85 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $64 |
| Journey Medical Corporation | 3 | $44 |
| Boehringer Ingelheim | 2 | $39 |
| Mayne Pharma Commercial LLC | 2 | $33 |
| Mimedx Group, Inc. | 1 | $29 |
| DUSA Pharmaceuticals, Inc. | 1 | $25 |
| Medtronic | 1 | $22 |
| Strata Skin Sciences, Inc. | 1 | $22 |
| Merz North America, Inc. | 1 | $21 |
| Sensus Healthcare, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Organon | 3 | $15 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Dermira, Inc. | 1 | $12 |
| Janssen Scientific Affairs, LLC | 1 | $11 |
How this compares
Too few dermatopathology providers in Illinoisto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 20 | $103,150 |
| SiliqBrodalumab | 14 | $71,907 |
| Humira(Cf) PenAdalimumab | 11 | $70,364 |
| Ivermectin | 18 | $6,704 |
| Fluorouracil | 59 | $4,322 |
| Metronidazole | 28 | $1,798 |
| Dapsone | 14 | $1,456 |
| Doxycycline Hyclate | 63 | $1,420 |
| Clobetasol Propionate | 33 | $1,301 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 28 | $1,109 |
| Ketoconazole | 85 | $1,076 |
| Betamethasone Dipropionate | 20 | $857 |
| ValacyclovirValacyclovir Hcl | 35 | $650 |
| Mupirocin | 87 | $572 |
| Minocycline Hcl | 16 | $442 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $239 | $103,15020 claims |
| Ortho Dermatologics, A Division Of Bausch Health US, LLCSiliq | $64 | $71,90714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few dermatopathology providers in Illinoison file to place this against a meaningful peer group, so we don't.
Other dermatopathology in Glen Carbon
- Brian NickoloffMaywood$116K
- Joan GuitartChicago$43K
- Vesna Petronic RosicChicago$11K
- Kayla St ClaireChicago$4K
- Kyla Price-JaureguiChicago$2K
- Cuong NguyenChicago$413
- Carl SoderstromPeoria$385
- Suzanne BirminghamElgin$244
- Sara Kullberg PearsonChicago$150
- Eugen MincaNaperville$102
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.